Gates fears a "dysfunctional" approach to distributing Covid-19 vaccines, despite an inspiring effort to produce promising candidates. | Continue reading
The company's CEO, Albert Bourla, said at the STAT Summit that Pfizer has collected the safety data necessary to submit an application. | Continue reading
Scientists have dreamed about the possibilities of custom-made messenger RNA. The pandemic may turn those possibilities into realilty. | Continue reading
The companies said an early analysis of results showed the vaccine to be more than 90% effective, beating expectations. | Continue reading
The road map to the new normal starts with a national vaccine confidence project led by the nation's best public health experts. | Continue reading
The vote represents a potential conundrum for the FDA, which had offered the treatment a glowing appraisal in advance. | Continue reading
Biden could be a potential disaster for the biotech industry. But its CEOs are supporting him more vocally than ever before. | Continue reading
A host of factors appear to be adding up to a slippage in the estimates of when vaccine will be ready to be deployed. | Continue reading
A host of factors appear to be adding up to a slippage in the estimates of when vaccine will be ready to be deployed. | Continue reading
The findings have prompted the agency to expand how it defines a “close contact” of someone with Covid-19. | Continue reading
A new survey from STAT and The Harris Poll finds the share of Americans who would get a Covid-19 vaccine once it’s available is falling. | Continue reading
Five events in a two-month span in 1980 propelled the nascent biotech industry and university biotech research into the future. | Continue reading
Lilly had reported its antibody reduced the amount of virus in patients’ nasal swabs and may have kept some patients out of the hospital. | Continue reading
The use of analytics software to target medical services to patients who need them most is infusing racial bias into health care decisions. | Continue reading
Clinical trial pauses are not uncommon, but they are generating outsized attention in the race to test Covid-19 vaccines. | Continue reading
Clinical trial pauses are not uncommon, but they are generating outsized attention in the race to test Covid-19 vaccines. | Continue reading
Despite the best of intentions and months of painstaking planning, expect snafus and confusion in the effort to get vaccines to people. | Continue reading
The monoclonal antibody treatment also appears to prevent patients from visiting the emergency room or hospital. | Continue reading
In an amended whistleblower complaint filed Tuesday, Bright said that he had only been given one assignment since being reassigned to the NIH. | Continue reading
Perspectives on Covid-19 transmission at the White House, caring for celebrity patients, and caring for geriatric patients with Covid-19. | Continue reading
In 'Dick Johnson is Dead,' his daughter Kirsten uses surreal staged enactments of her father's death to help deal with his memory loss. | Continue reading
Two new reports detail the internal strategies Celgene and Teva used to repeatedly hike the price of two blockbuster drugs. | Continue reading
As government agencies, hospital systems, and others track your Covid-19 searches, private companies are invading your online privacy. | Continue reading
Pinterest has taken a hardline strategy against health misinformation, and in particular, vaccine falsehoods. | Continue reading
A second study looked in unprecedented detail at the brains of pigeons and barn owls, finding hints to the basis of their intelligence. | Continue reading
A forthcoming study from 23andMe shows that a person’s genetic code could affect how severely they experience Covid-19. | Continue reading
The philanthropist, who has long warned of the need to prepare for pandemics, is dumbfounded by the U.S. response so far. | Continue reading
A forthcoming study from 23andMe shows that a person’s genetic code could affect how severely they experience Covid-19. | Continue reading
The large, Phase 3 study testing the vaccine has been put on hold due to a suspected serious adverse reaction in a participant in the U.K. | Continue reading
Nine drug companies pledged to submit Covid-19 vaccines for authorization only “after demonstrating safety and efficacy" in a Phase 3 study. | Continue reading
We need physician-scientists who can quickly translate observations made at Covid-19 patients' bedsides into therapies, like the yellow berets of yore. | Continue reading
Here is how a fast approval might play out, if all goes well — and some warning signs that normal procedure is not being followed. | Continue reading
The sentiment underscores speculation President Trump may pressure the FDA to approve or authorize emergency use of a Covid-19 vaccine before the election. | Continue reading
This Friday, Elon Musk's secretive brain-implants startup Neuralink will give the first major update on its progress in more than a year. | Continue reading
An advocacy group has asked the government to investigate "an apparent failure” by Moderna to disclose federal support for vaccine patent applications. | Continue reading
The CDC struggles with structural and cultural issues that have left the agency ill-equipped to fend off political attacks or to build up political capital. | Continue reading
As the world wearies of trying to suppress the SARS-CoV-2 virus, many of us are wondering what the future will look like as we try to learn to live with it. | Continue reading
A handful of hospitals and cancer clinics are tapping the cold calculations of AI to nudge conversations around some of the most deeply human questions. | Continue reading
Campaign surrogates, scientific advisers, and former U.S. health officials tell STAT Biden's election would set off a race to reverse the pandemic response. | Continue reading
Here are some of the things we have learned about Covid-19, and some of the pressing questions that we still need answered. | Continue reading
Researchers says they synthesized a molecule that is among the most powerful anti-coronavirus compounds tested in a lab to date. | Continue reading
Instead of telling people to stay home and avoid all nonessential social interactions, we should be teaching them how to socialize safely. | Continue reading
As many as 1 in 3 patients recovering from Covid-19 could experience neurological or psychological after-effects of their infections. | Continue reading
The United States has a chance to make things better before things get much, much worse. But much of the country appears to be squandering the opportunity. | Continue reading
The inequities resulted from a formula that allocated large chunks of a $175 billion relief package based on hospital revenue rather than Covid-19 cases. | Continue reading
Covid-19 is mainly transmitted through respiratory droplets in the air. Why isn't improving ventilation a key part of the effort to reopen schools? | Continue reading
Evidence is mounting that the temperature lab mice are kept in impacts the results of studies on cancer, metabolism, and inflammation. | Continue reading
Telemedicine giant Teladoc announced it will merge with chronic disease coaching company Livongo in an $18.5 billion deal. | Continue reading